Human BCL2L1 Protein

<strong>Human BCL2L1 Protein</strong>_x000D_ <strong>Catalog number:</strong> B2011634_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 100 µg_x000D_ <strong>Molecular Weight or Concentration:</strong> 1 mg/mL_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20 °C_x000D_ <strong>Keywords:</strong> Bcl(X)L protein, bcl-x protein, bcl-XL protein, bcl-L-1 protein, bcl2l protein, bclX protein, Bcl2l1 protein_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Sillars-Hardebol AH, Carvalho B, Beliën JA, de Wit M, Delis-van Diemen PM, Tijssen M, van de Wiel MA, Pontén F, Fijneman RJ, Meijer GA. BCL2L1 has a functional role in colorectal cancer and its protein expression is associated with chromosome 20q gain J Pathol. 2012 Feb;226(3):442-50._x000D_ 2: He Y, Zhang X, Chang J, Kim HN, Zhang P, Wang Y, Khan S, Liu X, Zhang X, Lv D, Song L, Li W, Thummuri D, Yuan Y, Wiegand JS, Ortiz YT, Budamagunta V, Elisseeff JH, Campisi J, Almeida M, Zheng G, Zhou D. Using proteolysis-targeting chimera technology to reduce navitoclax platelet toxicity and improve its senolytic activity Nat Commun. 2020 Apr 24;11(1):1996._x000D_ 3: Yosef R, Pilpel N, Tokarsky-Amiel R, Biran A, Ovadya Y, Cohen S, Vadai E, Dassa L, Shahar E, Condiotti R, Ben-Porath I, Krizhanovsky V. Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL Nat Commun. 2016 Apr 6;7:11190._x000D_ 4: Dai Y, Shaikho EM, Perez J, Wilson CA, Liu LY, White MR, Farrell JJ, Chui DHK, Sebastiani P, Steinberg MH. BCL2L1 is associated with γ-globin gene expression Blood Adv. 2019 Oct 22;3(20):2995-3001._x000D_ 5: Pawlak A, Henklewska M. The Role of Bcl-xL Protein Research in Veterinary Oncology Int J Mol Sci. 2020 Apr 4;21(7):2511._x000D_ 6: Guo T, Gu C, Li B, Xu C. Dual inhibition of FGFR4 and BCL-xL inhibits multi-resistant ovarian cancer with BCL2L1 gain Aging (Albany NY). 2021 Aug 5;13(15):19750-19759._x000D_ 7: Zhu Y, Doornebal EJ, Pirtskhalava T, Giorgadze N, Wentworth M, Fuhrmann-Stroissnigg H, Niedernhofer LJ, Robbins PD, Tchkonia T, Kirkland JL. New agents that target senescent cells: the flavone, fisetin, and the BCL-X(L) inhibitors, A1331852 and A1155463 Aging (Albany NY). 2017 Mar 8;9(3):955-963._x000D_ 8: Wyżewski Z, Świtlik W, Mielcarska MB, Gregorczyk-Zboroch KP. The Role of Bcl-xL Protein in Viral Infections Int J Mol Sci. 2021 Feb 16;22(4):1956._x000D_ 9: Li M, Wang D, He J, Chen L, Li H. Bcl-X(L): A multifunctional anti-apoptotic protein Pharmacol Res. 2020 Jan;151:104547._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/31067648">10: Lee EF, Fairlie WD. The Structural Biology of Bcl-x(L) Int J Mol Sci. 2019 May 7;20(9):2234. </a>_x000D_ _x000D_ <strong>Products Related to Human BCL2L1 Protein can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>